Page last updated: 2024-08-23

paclitaxel and Liver Diseases

paclitaxel has been researched along with Liver Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, N; Chopra, R; Li, Y; Palmisano, M; Ye, Y; Zhou, S1
Eren, B; Karaduman, D; Keles, ON1
Bhar, P; Biakhov, MY; Desai, N; Iglesias, J; Kononova, GV; Loibl, S; Schmid, AN1
Beijnen, JH; de Graeff, A; Huitema, AD; Huizing, MT; Joerger, M; Rosing, H; Schellens, JH; Vermorken, JB; Willemse, PH1
Fujita, H; Kojima, H; Mase, H; Okamoto, M; Takao, A1
Beijnen, JH; De Graeff, A; Huizing, MT; Panday, VR; ten Bokkel Huinink, WW; Vermorken, JB; Willemse, PH1
Crosignani, A; D'Incalci, M; Donelli, MG; Munzone, E; Zucchetti, M1
Clarke, SJ; Rivory, LP1
Blesch, K; Reigner, B; Weidekamm, E1
Samur, M1

Reviews

5 review(s) available for paclitaxel and Liver Diseases

ArticleYear
Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: disposition kinetics and pharmacology distinct from solvent-based paclitaxel.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Logistic Models; Male; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Nonlinear Dynamics; Paclitaxel; Young Adult

2014
Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function.
    Seminars in oncology, 1997, Volume: 24, Issue:4 Suppl 11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Liver; Liver Diseases; Paclitaxel

1997
Pharmacokinetics of anticancer agents in patients with impaired liver function.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:1

    Topics: Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Humans; Liver Diseases; Paclitaxel; Podophyllotoxin; Vinca Alkaloids

1998
Clinical pharmacokinetics of docetaxel.
    Clinical pharmacokinetics, 1999, Volume: 36, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Child; Clinical Trials as Topic; Docetaxel; Drug Interactions; Forecasting; Humans; Kidney Diseases; Liver Diseases; Paclitaxel; Protein Binding; Taxoids

1999
Clinical pharmacokinetics of capecitabine.
    Clinical pharmacokinetics, 2001, Volume: 40, Issue:2

    Topics: Antacids; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Food; Humans; Intestinal Absorption; Leucovorin; Liver Diseases; Paclitaxel; Protein Binding; Taxoids

2001

Trials

1 trial(s) available for paclitaxel and Liver Diseases

ArticleYear
nab-Paclitaxel in patients with advanced solid tumors and hepatic dysfunction: a pilot study.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:4

    Topics: Adult; Aged; Albumins; Antineoplastic Agents, Phytogenic; Female; Humans; Liver Diseases; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Paclitaxel; Pilot Projects

2010

Other Studies

4 other study(ies) available for paclitaxel and Liver Diseases

ArticleYear
The protective effect of beta-1,3-D-glucan on taxol-induced hepatotoxicity: a histopathological and stereological study.
    Drug and chemical toxicology, 2010, Volume: 33, Issue:1

    Topics: Animals; Antioxidants; beta-Glucans; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Free Radical Scavengers; Gastrointestinal Diseases; Glucans; Liver; Liver Diseases; Mice; Necrosis; Oxidative Stress; Paclitaxel; Proteoglycans; Rats; Rats, Sprague-Dawley; Rats, Wistar

2010
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study.
    British journal of clinical pharmacology, 2007, Volume: 64, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bilirubin; Biomarkers; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Paclitaxel; Sex Factors; Treatment Outcome

2007
[Pharmacokinetics of paclitaxel in experimental animals. Part 2. Tissue distribution].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:5

    Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Female; Half-Life; Injections, Intravenous; Liver Diseases; Male; Mice; Mice, Inbred ICR; Paclitaxel; Rabbits; Sarcoma 180; Tissue Distribution

1994
Docetaxel and liver dysfunction: is it absolutely contraindicated?
    American journal of clinical oncology, 2001, Volume: 24, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Contraindications; Docetaxel; Female; Humans; Liver Diseases; Middle Aged; Paclitaxel; Taxoids

2001